KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Other Accumulated Expenses (2022 - 2025)

QuidelOrtho's Other Accumulated Expenses history spans 4 years, with the latest figure at $281.4 million for Q1 2025.

  • For Q1 2025, Other Accumulated Expenses changed N/A year-over-year to $281.4 million; the TTM value through Mar 2025 reached $281.4 million, changed N/A, while the annual FY2024 figure was $288.7 million, 4.81% down from the prior year.
  • Other Accumulated Expenses for Q1 2025 was $281.4 million at QuidelOrtho, down from $288.7 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $334.0 million in Q2 2023 and bottomed at $114.4 million in Q1 2022.
  • The 4-year median for Other Accumulated Expenses is $288.7 million (2024), against an average of $269.7 million.
  • The largest YoY upside for Other Accumulated Expenses was 184.44% in 2023 against a maximum downside of 6.79% in 2023.
  • A 4-year view of Other Accumulated Expenses shows it stood at $240.5 million in 2022, then grew by 26.11% to $303.3 million in 2023, then dropped by 4.81% to $288.7 million in 2024, then fell by 2.53% to $281.4 million in 2025.
  • Per Business Quant, the three most recent readings for QDEL's Other Accumulated Expenses are $281.4 million (Q1 2025), $288.7 million (Q4 2024), and $303.3 million (Q4 2023).